Latest Content
Phage therapy for severe sepsis: where to next?
There is new optimism for phage therapy, an approach that has been with us for 100 years and is now being embraced anew. A rigorous clinical and biological approach will serve us well and effective partnerships between government, industry and the academy are essential.
Building a sustainable phage biobank – trials and tribulations
In an ideal world, a phage biobank would be a facility that serves as a primary research and therapeutic development resource for researchers studying critical infection, as well as to the wider community of infectious diseases, industry and biotech with an interest in critical infection.
Featured Contributors
Behind the paper
Share the real story behind your paper, from conception to publication, the highs and the lows.
Understanding the viral reservoirs of HIV
Between the mid to late 1990’s, the development and introduction of combination antiretroviral therapy (c-ART) transformed the landscape of HIV care for those with access to treatment.
From the editors
News, policy and social updates from the editors of Nature Microbiology and microbiology editors of other Nature titles
Drugs that mimic gut bacteria
Small-molecule drugs and biologics that alter the microbiome or its interaction with host tissues are poised to change the face of microbiome therapeutics.
On the road
Conferences, lab visits, vacations. Hear all about our editors travels and tell us about yours.
About the Community
Community updates, top tips and highlighted content.Welcome to our new home